Publicacións nas que colabora con FRANCISCO JAVIER O'VALLE RAVASSA (9)

2024

  1. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs

    British Journal of Pharmacology

2023

  1. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

    Gut Microbes, Vol. 15, Núm. 2

2021

  1. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  2. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  2. Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice

    Journal of hypertension, Vol. 38, Núm. 7, pp. 1322-1335

2019

  1. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus

    FASEB Journal, Vol. 33, Núm. 9, pp. 10005-10018

2017

  1. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus

    Hypertension, Vol. 69, Núm. 4, pp. 641-650